116 related articles for article (PubMed ID: 11423937)
41. Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells.
Hillman GG; Kallinteris NL; Li J; Wang Y; Lu X; Li Y; Wu S; Wright JL; Slos P; Gulfo JV; Humphreys RE; Xu M
Gene Ther; 2003 Aug; 10(17):1512-8. PubMed ID: 12900767
[TBL] [Abstract][Full Text] [Related]
42. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
[TBL] [Abstract][Full Text] [Related]
43. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity.
Salisbury CL; Budnick SD; Li S
Am J Clin Pathol; 2009 Nov; 132(5):722-7. PubMed ID: 19846813
[TBL] [Abstract][Full Text] [Related]
44. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma.
Heald P; Yan SL; Edelson R
Arch Dermatol; 1994 Feb; 130(2):198-203. PubMed ID: 8304758
[TBL] [Abstract][Full Text] [Related]
45. Human antibodies targeting CD30(+) lymphomas.
Wezler X; Hust M; Helmsing S; Schirrmann T; Dübel S
Hum Antibodies; 2012; 21(1-2):13-28. PubMed ID: 22885957
[TBL] [Abstract][Full Text] [Related]
46. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
47. Alterations in CD30(+) T cells in monoclonal gammopathy of undetermined significance.
Ellis TM; Le PT; DeVries G; Stubbs E; Fisher M; Bhoopalam N
Clin Immunol; 2001 Mar; 98(3):301-7. PubMed ID: 11237552
[TBL] [Abstract][Full Text] [Related]
48. Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma.
Hansen ER
Arch Dermatol; 1996 May; 132(5):554-61. PubMed ID: 8624153
[TBL] [Abstract][Full Text] [Related]
49. A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
Hombach A; Schlimper C; Sievers E; Frank S; Schild HH; Sauerbruch T; Schmidt-Wolf IG; Abken H
Gut; 2006 Aug; 55(8):1156-64. PubMed ID: 16188919
[TBL] [Abstract][Full Text] [Related]
50. Identification of HLA class I dependent immunogenic peptides from clonotypic TCRbeta expressed in cutaneous T-cell lymphoma.
Zeng J; Müller-Berghaus J; Nguyen XD; Klüter H; Schönhaber H; Song M; Schwinn N; Schadendorf D; Goerdt S; Eichmüller S; Dippel E
Int J Cancer; 2006 Nov; 119(10):2476-80. PubMed ID: 16858680
[TBL] [Abstract][Full Text] [Related]
51. Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv/CD28/CD3zeta recombinant gene.
Yu K; Hu Y; Tan Y; Shen Z; Jiang S; Qian H; Liang B; Shan D
Leuk Lymphoma; 2008 Jul; 49(7):1368-73. PubMed ID: 18452062
[TBL] [Abstract][Full Text] [Related]
52. T-cell receptor-γ in gamma-delta phenotype cutaneous T-cell lymphoma can be accompanied by atypical expression of CD30, CD4, or TCRβF1 and an indolent clinical course.
Vin H; Talpur R; Tetzlaff MT; Duvic M
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e195-200. PubMed ID: 25088535
[No Abstract] [Full Text] [Related]
53. Chimeric antigen receptors for T-cell based therapy.
Cheadle EJ; Sheard V; Hombach AA; Chmielewski M; Riet T; Berrevoets C; Schooten E; Lamers C; Abken H; Debets R; Gilham DE
Methods Mol Biol; 2012; 907():645-66. PubMed ID: 22907378
[TBL] [Abstract][Full Text] [Related]
54. Dystrophic xanthomatosis in primary CD30-positive cutaneous T-cell lymphoma. Report of two cases and review of the literature.
Giménez S; Gallardo F; Curcó N; Marcoval J; Romagosa V; Servitje O; Pujol RM
Dermatology; 2005; 211(3):267-72. PubMed ID: 16205073
[TBL] [Abstract][Full Text] [Related]
55. CD30+ clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome.
Kempf W; Kazakov DV; Szep Z; Vanecek T
J Cutan Pathol; 2015 Feb; 42(2):130-5. PubMed ID: 25421540
[TBL] [Abstract][Full Text] [Related]
56. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen.
Gianotti R; Alessi E; Cavicchini S; Berti E
Am J Dermatopathol; 1991 Oct; 13(5):503-8. PubMed ID: 1659246
[TBL] [Abstract][Full Text] [Related]
57. Intralymphatic CD30+ T-cell proliferation during DRESS: a mimic of intravascular lymphoma.
Weingertner N; Mitcov M; Chenard MP; Cribier B
J Cutan Pathol; 2016 Nov; 43(11):1036-1040. PubMed ID: 27433889
[TBL] [Abstract][Full Text] [Related]
58. Neurotropic Gamma-Delta T-Cell Lymphoma With CD30-Positive Lymphoid Infiltrates.
Gammon B; Gammon BR; Kim YH; Kim J
Am J Dermatopathol; 2016 Sep; 38(9):e133-6. PubMed ID: 27391454
[TBL] [Abstract][Full Text] [Related]
59. Predominant rearrangements of the T cell receptor beta-chain gene in blood lymphocyte populations stimulated with autologous tumor cells suggest clonal T cell expansion in two of fourteen cases.
Stuber G; Vánky F; Wen T; Chan A; Klein E; Mak TW
Immunol Lett; 1991 Nov; 30(3):313-8. PubMed ID: 1666061
[TBL] [Abstract][Full Text] [Related]
60. T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity.
Chmielewski M; Hombach A; Heuser C; Adams GP; Abken H
J Immunol; 2004 Dec; 173(12):7647-53. PubMed ID: 15585893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
